Material Handler at Bristol-Myers Squibb

Leiden, South Holland, Netherlands

Apply Now

Not SpecifiedCompensation

Entry Level & New Grad, Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, Cell TherapyIndustries

Requirements

Relevant education or experience in Science, Facilities and Engineering on VMBO / MBO level
Experience in a cGMP warehouse environment and understanding of Materials Management
General dangerous goods experience and certifications are a plus
Experience with receiving, temperature storage, issuance, and inventory control practices including cycle counting, and rejected/expired material disposition
Experience in cold chain logistical movement of time

Responsibilities

Executes internal and external temperature controlled Material requests across multiple unit operations under cleanroom conditions
Completing (electronic) documentation required by process transfer protocols, standard operating procedures, and batch records
Responding to system and equipment alarms during inside / outside office hours in rotating schedule
Assisting in setting up warehouse operations equipment/fixtures and support facility and equipment commissioning activities
Performing tasks in a manner that is consistent with departmental and corporate safety policies, quality systems and GMP requirements
Additional duties, tasks and responsibilities as assigned by Senior Management

Skills

Material Handling

Manufacturing

GMP

Warehouse Operations

Inventory Management

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free